Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Diagnosing Frontal Fibrosing Alopecia by Evaluating Facial Hyperpigmentation

Description

This presentation discusses the diagnosis of facial hyperpigmentation, particularly in patients suffering from frontal fibrosing alopecia (FFA). Facial hyperpigmentation is a prevalent issue that can significantly impact self-esteem and emotional well-being, especially among patients with darker skin tones. A range of causes is identified, including melasma, post-inflammatory hyperpigmentation (PIH) from conditions like acne, and UV-induced changes in older patients. The speaker highlights the importance of accurate diagnosis to provide effective treatment. The association between facial hyperpigmentation and FFA is examined, noting that this inflammatory condition typically affects post-menopausal women but is increasingly recognized in men and younger individuals. Key symptoms include hair loss at the hairline, eyebrow involvement, and facial papules. Diagnostic methods such as dermoscopy and biopsy are emphasized for identifying FFA and associated hyperpigmentation. Moreover, the speaker points out the role of products like sunscreens in exacerbating these conditions, recommending the use of mineral sunscreens that also provide visible light protection. The presentation concludes by stressing the need for proper diagnosis and treatment of hyperpigmentation and encourages referrals to supportive organizations for affected patients.

View more

Conclusions

  • Facial hyperpigmentation is a common dermatological issue in patients of color, affecting self-esteem and quality of life.
  • Correct diagnosis is essential for effective treatment of facial hyperpigmentation.
  • Post-inflammatory hyperpigmentation (PIH) related to acne is prevalent and significantly impacts patient's mental health and emotional functioning.
  • Facial hyperpigmentation presents differently based on skin type, with melasma, PIH, and age-related hyperpigmentation being more common in darker skin types.
  • Frontal fibrosing alopecia (FFA) is increasingly recognized as being associated with facial hyperpigmentation, particularly in Black patients.
  • There is an emerging concern regarding the role of certain skincare products, particularly sunscreens and moisturizers, in the development of FFA.
  • Photoprotection is crucial in the management of facial hyperpigmentation and should be reinforced in treatment plans.
  • Education on sun protection and the appropriate use of sunscreens can help manage and prevent exacerbation of hyperpigmentation disorders.
  • Davis et al., 2012
  • Chen et al., 2024
  • Pichardo-Geisinger, R.O., McMichael, A.J., et al. (2012). Top Dermatologic Conditions in Patients of Color: An Analysis of Nationally Representative Data. Journal of Drugs in Dermatology, 466, April 2012, Volume II, Issue 4.
  • Archives of Dermatological Research (2024) 316:459
  • https://doi.org/10.1007/s00403-024-03198-4
  • Alexis, A., Boyd, C., Callender, V., Downie, J., Sangha, S., Understanding the Female African American Facial Aesthetic Patient. JDD 2019;18(9):858-866.
  • Esposito, A. et al. (2022). Dermatol Ther 12(9): 1967-1988.
  • Darji, K. et al. (2017). JCAD 10(5):18-23.
  • Sonthalia, S. et al. (2020). Dermatol Pract Concept 10(2).
  • Goyal, P. et al. CosmoDerma (2024).
  • Ladizinski, B. et al. (2013). JAAD 68:749-755.
  • Vano-Galvan, S. et al. JAAD 2014;70:670-678.
  • Tosti, A. et al. (2011). Arch Derm 147:1240.
  • lorizzo, M., Tosti, A. (2019). Am J Clin Dermatol 20(3):379-390.
  • Adotama, P., Callender, V.D. et al. (2021). Br J Dermatol. 185(5):1074-1076.
  • Ho, Shapiro. (2019). JAAD.
  • Pindado-Ortega, C. et al. (2021). JAAD 84:1285-94.
  • Shah, P. et al. (2020). JAAD Case Reports 6:812-4.
  • Dispenza, M.C. et al. (2012). J Invest Dermatol 132(9):2798-2205.
  • Falcon, R.H. et al. (1986). J Invest Dermatol 86(5):550-552.
  • Rigel, D.F. et al. JAAD 2022;86(3):SI-S8.